Tag Archives: FDA approved

Biosimilar: Expansion of pharmaceutical industry

Innovations of new drugs in the pharmaceutical industry, like biosimilars, are opening new opportunities for the pharmaceutical industry and a wide […]

February 16, 2023

US FDA Approves Tecvayli® (Teclistamab-cqyv) for Relapsed/Refractory Multiple Myeloma (RRMM)

On October 25, 2022, the US FDA granted accelerated approval to Tecvayli® (teclistamab-cqyv, Janssen Biotech, Inc.) for adult patients with […]

October 28, 2022

US FDA Approves Boostrix for Whooping Cough (Pertussis) Prevention in Infants Aged Younger Than Two Months

On October 07, 2022, the U.S. FDA approved GlaxoSmithKline’s Boostrix (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed […]

October 11, 2022